Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Systemic Lupus Erythematosus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07470151
What this trial is testing

Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases

Who this might be right for
System Lupus Erythematosus(SLE)SclerodermaMyasthenia Gravis (MG)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12
Testing effectiveness (Phase 2)Study completedNCT00997100
What this trial is testing

Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Active Biotech AB 13
Not applicableNot Yet RecruitingNCT07780045
What this trial is testing

SII and SIRI as Prognostic Biomarkers in Lupus Nephritis

Who this might be right for
Lupus NephritisSystemic Lupus ErythematosusKidney Diseases
Assiut University 100
Testing effectiveness (Phase 2)UnknownNCT01741857
What this trial is testing

Umbilical Cord Derived Mesenchymal Stem Cells Transplantation for Active and Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 40
Not applicableLooking for participantsNCT07424261
What this trial is testing

NIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine Care

Who this might be right for
Lupus Erythematosus, Systemic
AstraZeneca 125
Testing effectiveness (Phase 2)UnknownNCT01863641
What this trial is testing

The Effect of Calcitriol on Progress and Activity of Lupus Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Guilan University of Medical Sciences 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05126277
What this trial is testing

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 452
Post-approval studies (Phase 4)Study completedNCT01705977
What this trial is testing

Belimumab Assessment of Safety in SLE

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 4,019
Not applicableLooking for participantsNCT05443516
What this trial is testing

Disease Activity Biomarkers in Patients With Systemic Lupus Erythematosus

Who this might be right for
Lupus Nephritis
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 250
Testing effectiveness (Phase 2)Study completedNCT00962832
What this trial is testing

Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Genentech, Inc. 238
Post-approval studies (Phase 4)Active Not RecruitingNCT05879419
What this trial is testing

Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisSpondylitis, AnkylosingSpondyloarthritis+8 more
University of Sao Paulo General Hospital 2,005
Large-scale testing (Phase 3)WithdrawnNCT06456567
What this trial is testing

Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2)

Who this might be right for
Systemic Lupus Erythematosus
Vor Biopharma
Testing effectiveness (Phase 2)Ended earlyNCT05781750
What this trial is testing

Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)

Who this might be right for
Lupus Nephritis
Kezar Life Sciences, Inc. 84
Not applicableStudy completedNCT01892748
What this trial is testing

Cholecalciferol Supplementation on Disease Activity, Fatigue and Bone Mass on Juvenile Systemic Lupus Erythematosus.

Who this might be right for
Systemic Lupus Erythematosus
ROSA MARIA RODRIGUES PEREIRA 60
Testing effectiveness (Phase 2)Study completedNCT02725515
What this trial is testing

The Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Xencor, Inc. 105
Testing effectiveness (Phase 2)Ended earlyNCT04376827
What this trial is testing

Guselkumab in Participants With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Janssen Research & Development, LLC 33
Testing effectiveness (Phase 2)Study completedNCT00976300
What this trial is testing

Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Institute of Rheumatology, Prague 40
Not applicableUnknownNCT06063668
What this trial is testing

Autotaxin as Abiomarker in Systemic Lupus Erythematosus Patients

Who this might be right for
SLE (Systemic Lupus)
Assiut University 94
Large-scale testing (Phase 3)Ended earlyNCT00383214
What this trial is testing

Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
UCB Pharma 54
Not applicableTemporarily pausedNCT06310811
What this trial is testing

Anti-CD19 CAR-T Cell Therapy in Participants With Moderate to Severe Active Systemic Lupus Erythematosus

Who this might be right for
SafetyEffective
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12
Next Page